Calamos Advisors LLC Sells 1,165 Shares of Cerner Co. (CERN)
Calamos Advisors LLC reduced its position in shares of Cerner Co. (NASDAQ:CERN) by 2.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 54,892 shares of the company’s stock after selling 1,165 shares during the period. Calamos Advisors LLC’s holdings in Cerner were worth $3,699,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Fuller & Thaler Asset Management Inc. acquired a new stake in Cerner in the third quarter valued at $121,000. Steward Partners Investment Advisory LLC acquired a new stake in Cerner in the third quarter valued at $128,000. Cerebellum GP LLC acquired a new stake in Cerner in the fourth quarter valued at $127,000. Archford Capital Strategies LLC raised its holdings in Cerner by 1,286.0% in the third quarter. Archford Capital Strategies LLC now owns 2,980 shares of the company’s stock valued at $213,000 after acquiring an additional 2,765 shares in the last quarter. Finally, Bluestein R H & Co. acquired a new stake in Cerner in the third quarter valued at $214,000. 77.77% of the stock is currently owned by institutional investors and hedge funds.
CERN has been the topic of several recent analyst reports. Zacks Investment Research raised shares of Cerner from a “hold” rating to a “buy” rating and set a $79.00 price target on the stock in a report on Tuesday, January 9th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $70.00 price target on shares of Cerner in a report on Thursday, November 30th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $75.00 price target on shares of Cerner in a report on Wednesday, November 29th. Royal Bank of Canada reaffirmed a “buy” rating and issued a $74.00 price target on shares of Cerner in a report on Wednesday, November 22nd. Finally, Robert W. Baird reaffirmed a “buy” rating on shares of Cerner in a report on Wednesday, January 3rd. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and nine have issued a buy rating to the company’s stock. Cerner currently has an average rating of “Hold” and a consensus target price of $67.55.
Cerner (NASDAQ:CERN) last issued its earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.61 by ($0.03). The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.33 billion. Cerner had a return on equity of 16.82% and a net margin of 16.86%. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period last year, the company posted $0.61 earnings per share. sell-side analysts anticipate that Cerner Co. will post 2.42 EPS for the current fiscal year.
In other news, VP Jeffrey A. Townsend sold 230,000 shares of the company’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $61.94, for a total transaction of $14,246,200.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Michael R. Battaglioli sold 4,000 shares of the company’s stock in a transaction dated Wednesday, December 13th. The stock was sold at an average price of $69.89, for a total transaction of $279,560.00. Following the transaction, the vice president now owns 4,000 shares of the company’s stock, valued at approximately $279,560. The disclosure for this sale can be found here. Insiders have sold 288,100 shares of company stock worth $18,280,616 over the last three months. 13.11% of the stock is owned by corporate insiders.
Cerner Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.